Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Kidney Transplant I: Introduction

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Kidney Transplant II: Surgical Procedure

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

CNS Embryonal Tumor with PLAGL Amplification, a New Tumor in Children and Adolescents: Insights from a Comprehensive MRI Analysis.

AJNR. American journal of neuroradiology·2024

Same author

Intravenous thrombolysis for multi-ethnic Asians with acute ischaemia stroke in Malaysian public primary stroke centres versus acute stroke ready hospitals: Comparison of real-world clinical outcomes.

The Medical journal of Malaysia·2023

Same author

Rehabilitation after proximal interphalangeal joint replacement: A structured review of the literature.

Hand surgery & rehabilitation·2021

Same author

The road map toward an hepatitis C virus-free transplant population.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2018

Same author

Safety of sofosbuvir-based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study.

Alimentary pharmacology & therapeutics·2018

Same author

The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities.

Journal of viral hepatitis·2018

Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014

Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014

Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014

Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014

Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014

Same journal

[Not Available].

Gastroenterologie clinique et biologique·2014

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 22, 2026

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

[Hepatic transplantation].

C Duvoux¹, D Samuel

¹Service d'Hépatologie de Gastroentérologie, Hôpital Henri-Mondor, Assistance Publique-Hôpitaux de Paris, Université Paris 12, 94010 Créteil cedex, France.

Gastroenterologie Clinique Et Biologique

|June 27, 2009

Summary

This summary is machine-generated.

Liver transplantation (LT) is a vital treatment for end-stage liver disease, with improving survival rates. Key challenges include organ shortage and immunosuppression side effects, driving research into organ recruitment and tolerance induction.

More Related Videos

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice

Published on: February 10, 2018

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Published on: September 13, 2014

Related Experiment Videos

Last Updated: Jun 22, 2026

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice

Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice

Published on: February 10, 2018

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Published on: September 13, 2014

Area of Science:

Hepatology
Transplantation Surgery
Immunology

Background:

Liver transplantation (LT) has evolved significantly since 1963, becoming a standard treatment for end-stage liver diseases.
Indications have expanded, with early-stage hepatocellular carcinoma, cirrhosis (Hepatitis C and alcoholic), being primary adult reasons.
European data shows 5000 LTs annually, with survival rates of 86% at 1 year, 75% at 5 years, and 68% at 10 years (2000-2006).

Purpose of the Study:

To review the advancements and current status of liver transplantation.
To identify the primary challenges and future research directions in the field.
To highlight the progress in surgical techniques, immunosuppression, and organ allocation.

Main Methods:

Review of historical data and current practices in liver transplantation.
Analysis of survival rates and indications for LT in Europe.
Discussion of advancements in immunosuppressive drugs and organ procurement strategies.

Main Results:

Significant improvements in surgical techniques, immunosuppression (tacrolimus, mycophenolic acid, etc.), and organ allocation policies have enhanced LT outcomes.
Rejection incidence is now less than 20% due to advanced immunosuppressive drugs.
Surgical innovations like split liver, domino LT, and living donor transplantation have expanded organ availability.

Conclusions:

Liver transplantation is a successful treatment for end-stage liver disease, but organ shortage and long-term immunosuppression complications remain significant hurdles.
Future efforts should focus on optimizing organ recruitment (e.g., non-heart beating donation, intrafamilial donation) and developing novel immunosuppressive strategies to induce tolerance.
Research into molecular signatures of tolerant patients and methods like lymphocyte depletion or costimulation blockade are promising for reducing immunosuppression-related complications.